194 related articles for article (PubMed ID: 15907369)
1. Protein kinase C (PKC) family in cancer progression.
Koivunen J; Aaltonen V; Peltonen J
Cancer Lett; 2006 Apr; 235(1):1-10. PubMed ID: 15907369
[TBL] [Abstract][Full Text] [Related]
2. [Study on the molecular structure and function of protein kinase C isoenzyme].
He ZW; Yao KT
Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):307-13. PubMed ID: 12501658
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C and other diacylglycerol effectors in cancer.
Griner EM; Kazanietz MG
Nat Rev Cancer; 2007 Apr; 7(4):281-94. PubMed ID: 17384583
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
5. Evidence that protein kinase Calpha interacts with and regulates the glial glutamate transporter GLT-1.
González MI; Susarla BT; Robinson MB
J Neurochem; 2005 Sep; 94(5):1180-8. PubMed ID: 16045453
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
van der Merwe JQ; Moreau F; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of PKC isozymes by RNA interference and inducible expression of PKC constructs.
Basu A; Persaud SD; Sivaprasad U
Methods Enzymol; 2008; 446():141-57. PubMed ID: 18603120
[TBL] [Abstract][Full Text] [Related]
8. PKC isozymes and diacylglycerol-regulated proteins as effectors of growth factor receptors.
Oliva JL; Griner EM; Kazanietz MG
Growth Factors; 2005 Dec; 23(4):245-52. PubMed ID: 16338787
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C isoenzymes: regulation and function.
Blobe GC; Stribling S; Obeid LM; Hannun YA
Cancer Surv; 1996; 27():213-48. PubMed ID: 8909803
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C alpha and delta.
Haughian JM; Jackson TA; Koterwas DM; Bradford AP
Endocr Relat Cancer; 2006 Dec; 13(4):1251-67. PubMed ID: 17158769
[TBL] [Abstract][Full Text] [Related]
11. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
[TBL] [Abstract][Full Text] [Related]
12. Role of protein kinase C in expression of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
Int J Mol Med; 2005 Nov; 16(5):873-81. PubMed ID: 16211258
[TBL] [Abstract][Full Text] [Related]
13. Classical PKC isoforms in cancer.
Martiny-Baron G; Fabbro D
Pharmacol Res; 2007 Jun; 55(6):477-86. PubMed ID: 17548205
[TBL] [Abstract][Full Text] [Related]
14. A spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation.
Collazos A; Diouf B; Guérineau NC; Quittau-Prévostel C; Peter M; Coudane F; Hollande F; Joubert D
Mol Cell Biol; 2006 Mar; 26(6):2247-61. PubMed ID: 16508001
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice.
Oster H; Leitges M
Cancer Res; 2006 Jul; 66(14):6955-63. PubMed ID: 16849539
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model.
Lin X; Yu Y; Zhao H; Zhang Y; Manela J; Tonetti DA
Carcinogenesis; 2006 Aug; 27(8):1538-46. PubMed ID: 16513679
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
[TBL] [Abstract][Full Text] [Related]
18. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase C (PKC) family of proteins in cytokine signaling in hematopoiesis.
Redig AJ; Platanias LC
J Interferon Cytokine Res; 2007 Aug; 27(8):623-36. PubMed ID: 17784814
[TBL] [Abstract][Full Text] [Related]
20. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury.
Churchill EN; Mochly-Rosen D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1040-2. PubMed ID: 17956273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
